These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 15001985

  • 1. Collaborative activities of macrophage-stimulating protein and transforming growth factor-beta1 in induction of epithelial to mesenchymal transition: roles of the RON receptor tyrosine kinase.
    Wang D, Shen Q, Chen YQ, Wang MH.
    Oncogene; 2004 Mar 04; 23(9):1668-80. PubMed ID: 15001985
    [Abstract] [Full Text] [Related]

  • 2. Activation of the RON receptor tyrosine kinase attenuates transforming growth factor-beta1-induced apoptotic death and promotes phenotypic changes in mouse intestinal epithelial cells.
    Wang D, Shen Q, Xu XM, Chen YQ, Wang MH.
    Carcinogenesis; 2005 Jan 04; 26(1):27-36. PubMed ID: 15447977
    [Abstract] [Full Text] [Related]

  • 3. Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein.
    Ma Q, Guin S, Padhye SS, Zhou YQ, Zhang RW, Wang MH.
    Mol Cancer; 2011 May 28; 10():66. PubMed ID: 21619683
    [Abstract] [Full Text] [Related]

  • 4. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells.
    Rhyu DY, Yang Y, Ha H, Lee GT, Song JS, Uh ST, Lee HB.
    J Am Soc Nephrol; 2005 Mar 28; 16(3):667-75. PubMed ID: 15677311
    [Abstract] [Full Text] [Related]

  • 5. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J, Dai C, Liu Y.
    J Am Soc Nephrol; 2005 Jan 28; 16(1):68-78. PubMed ID: 15537870
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells.
    Park JS, Choi HI, Kim DH, Kim CS, Bae EH, Ma SK, Kim SW.
    Int J Mol Sci; 2019 Nov 04; 20(21):. PubMed ID: 31690042
    [Abstract] [Full Text] [Related]

  • 8. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells.
    Fujimoto K, Sheng H, Shao J, Beauchamp RD.
    Exp Cell Res; 2001 Jun 10; 266(2):239-49. PubMed ID: 11399052
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prostaglandin E2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor.
    Zhang A, Wang MH, Dong Z, Yang T.
    Am J Physiol Renal Physiol; 2006 Dec 10; 291(6):F1323-31. PubMed ID: 16868306
    [Abstract] [Full Text] [Related]

  • 11. Mechanisms of RON-mediated epithelial-mesenchymal transition in MDCK cells through the MAPK pathway.
    Xiangming X, Yun Q, Guoliang Z, Jianjiang L, Lisong T.
    Braz J Med Biol Res; 2011 Jul 10; 44(7):634-41. PubMed ID: 21655705
    [Abstract] [Full Text] [Related]

  • 12. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
    Zeisberg M, Hanai J, Sugimoto H, Mammoto T, Charytan D, Strutz F, Kalluri R.
    Nat Med; 2003 Jul 10; 9(7):964-8. PubMed ID: 12808448
    [Abstract] [Full Text] [Related]

  • 13. Effects of growth and differentiation factors on the epithelial-mesenchymal transition in cultured neonatal rat hepatocytes.
    Pagan R, Sánchez A, Martin I, Llobera M, Fabregat I, Vilaró S.
    J Hepatol; 1999 Nov 10; 31(5):895-904. PubMed ID: 10580588
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. High-Mobility Group Box 1 Mediates Epithelial-to-Mesenchymal Transition in Pulmonary Fibrosis Involving Transforming Growth Factor-β1/Smad2/3 Signaling.
    Li LC, Li DL, Xu L, Mo XT, Cui WH, Zhao P, Zhou WC, Gao J, Li J.
    J Pharmacol Exp Ther; 2015 Sep 10; 354(3):302-9. PubMed ID: 26126535
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT).
    Kasai H, Allen JT, Mason RM, Kamimura T, Zhang Z.
    Respir Res; 2005 Jun 09; 6(1):56. PubMed ID: 15946381
    [Abstract] [Full Text] [Related]

  • 18. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
    Ellenrieder V, Hendler SF, Boeck W, Seufferlein T, Menke A, Ruhland C, Adler G, Gress TM.
    Cancer Res; 2001 May 15; 61(10):4222-8. PubMed ID: 11358848
    [Abstract] [Full Text] [Related]

  • 19. TGF-beta1-mediated alterations of renal proximal tubular epithelial cell phenotype.
    Tian YC, Fraser D, Attisano L, Phillips AO.
    Am J Physiol Renal Physiol; 2003 Jul 15; 285(1):F130-42. PubMed ID: 12644442
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.